Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 155 (4) , 1098-1108.e9
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive Kidney Diseases (U01DK092239)
- Crohn's and Colitis Foundation ((P30 DK034987)
- Crohn’s and Colitis Foundation and the National Institutes of Health
This publication has 40 references indexed in Scilit:
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2012
- Efficacy of methotrexate in ulcerative colitisInflammatory Bowel Diseases, 2010
- Methotrexate for maintenance of remission in Crohn's disease2009
- Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritisRheumatology, 2007
- Methotrexate for induction of remission in ulcerative colitis2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitisGut, 2005
- A randomized dose–response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn’s disease and ulcerative colitisAlimentary Pharmacology & Therapeutics, 1999
- Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trialGastroenterology, 1996
- Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.BMJ, 1992